ascopubs.org

The association of hormone receptor expression level and clinical efficacy of CDK4/6 inhibitor in hormone receptor-positive, HER2-negative metastatic breast cancer.

Effect of timing of recurrence on outcomes in patients with metastatic breast cancer treated with CDK4/6 inhibitors. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract ...
CURE

New Test Predicts Breast Cancer Recurrence and Radiation Therapy Benefit

A Decision Score provides prognostic discrimination for 10-year locoregional recurrence, with rising score associated with ...
ascopubs.org

Repurposing hemostatic drug desmopressin in AVPR2-expressing triple-negative breast cancer: Target expression analysis and preclinical antineoplastic effects on tumor growth ...

Effect of DeltaRex-G ± DeltaRex-G Plus (an FDA-approved drug) on advanced chemoresistant pancreatic cancer, sarcoma, and breast cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...
Frontiers

Unraveling Breast Cancer Complexity: Insights from Single-Cell Sequencing and Spatial Transcriptomics

Breast cancer remains one of the most prevalent and life-threatening forms of cancer, impacting millions worldwide. This malignancy's heterogeneity and complexity have long posed significant ...

Scientists Discover Molecular “Switch” That Could Stop Breast Cancer From Spreading

A receptor involved in normal physiological processes may also drive breast cancer growth when overexpressed.
News Medical

The association between neighborhood deprivation, DNA methylation, and gene expression in breast tissue for Black and White women with breast cancer

Despite advances in breast cancer treatment reducing mortality across all racial and ethnic groups, Black women face a 40% higher death rate than White women. Socioeconomic disparities, notably in ...